GEn1E Lifesciences
Manufacturing · 11-50 Employees
View Company Info for Free
Overview
Phone Number
(650) 799-8072Website
www.gen1elifesci.comRevenue
<$5 MillionIndustry
ZI Rank: 1
Signal Type
Feb
Mar
Apr
May
Jun
Jul
ZI Rank
1
1
1
1
1
1
About GEn1E Lifesciences
GEn1E Lifesciences is a multitarget platform for novel, next generation immunomodulators for rare and inflammatory diseases. By applying machine learning to its "platform in a mechanism" model, GEn1E has developed a pipeline of 21+ novel compounds. Their lead compound is a purpose-built therapy for acute respiratory distress syndrome (ARDS), a serious respiratory condition with no approved therapeutic treatments and high mortality rate.Explore more
Popular SearchesGen1e Lifesciences IncGen1e LifesciencesGen1e Lifesciences LLCUniversity of MarylandSIC Code 28,283NAICS Code 32,325Show moreGEn1E Lifesciences Org Chart
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Is GEn1E Lifesciences your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Funding: Get notified immidiatlly once GEn1E Lifesciences has new funding data
GEn1E Lifesciences, which may be a good buyer, showed buying intent in Masked Content Topic
Product Launch: Get notified when GEn1E Lifesciences launches new products
Check out if GEn1E Lifesciences is spiking on competitors!
Click to see if GEn1E Lifesciences had a recent Job posting/layoffs
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Website visits: Recent activity has been detected on your website
Check if GEn1E Lifesciences has recently received funding, and reach out quickly before it becomes old news!
Earning: See what the market has to say on GEn1E Lifesciences recently announced quarterly report
Congratulate Masked Content for being promoted to Masked Content at GEn1E Lifesciences
Recommended Actions
Reach out to Masked Content who joined GEn1E Lifesciences as Masked Content
Find 2 more new buyers
Compare Similar Companies to GEn1E Lifesciences
Compare insights from companies similar to GEn1E Lifesciences, focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.
Revenue
Number of Employees
Type
Funding
Founded In
Company Profile Activity
Activity Insights
GEn1E Lifesciences is experiencing very low activity levels compared to other companies in the Manufacturing sector.
What does this means?
GEn1E Lifesciences is drawing exceptional interest within the Manufacturing industry, suggesting notable developments or strong market momentum, learn more about GEn1E Lifesciences.
GEn1E Lifesciences Tech Stack
A closer look at the technologies used by GEn1E Lifesciences
See more technologies
Most Recent Scoops
Project
Laboratory Operations, Medical Research, Clinical Operations
New Hire
Executive Move
New Hire
Executive Move
New Hire
Executive Move
GEn1E Lifesciences News & Media
GEn1E Lifesciences Publishes Breakthrough Research Unveiling Novel Mechanism of Action of Dual Signal Modulators for Anti-inflammatory and Endothelial-Stabilizing Therapies
GEn1E Lifesciences today announced the publication of a landmark study in the prestigious Journal of Pharmacology and Experimental Therapeutics (JPET)Dr. Sham Dholakia joins GEn1E Lifesciences as Chief Medical Officer, as it further scales its AI/ML platform, portfolio and partnerships
Former Chief Medical Officer (CMO) of CareDx, Inc. and seasoned medical executive with track record of transforming organizations will join GEn1E Lifesciences as the CMO in Jan 2023 and will lead clinical development, accelerating the development of a new class of targeted therapies to...Inflect Health Expands its Strategic Partnership with GEn1E Lifesciences to Combat Rare & Inflammatory Diseases
Partnership enables GEn1E to accelerate its AI/ML Platform to advance novel immunomodulatory therapies using Inflect's healthcare expertise EMERYVILLE, Calif. and PALO ALTO, Calif., May 12, 2022 /PRNewswire/ -- Inflect Health, the innovation hub of Vituity, a physician-owned and operated...Vituity and GEn1E Lifesciences Announce Strategic Partnership
EMERYVILLE, Calif.--(BUSINESS WIRE)--Vituity, a nationwide, physician-owned-and-led multispecialty partnership, and GEn1E Lifesciences, a Y Combinator and StartX company focused on accelerating cures for diseases of inflammation and aging, today announced a new strategic partnership to speed up development of COVID-19 treatments and improve patient outcomes. As part of the new partnership, GEn1E will leverage Vituity’s deep healthcare expertise to optimize the design and efficiency of clinical
Read more news
Top Manufacturing Companies
Top companies in Canada by revenue
Top companies in Australia by revenue
Top companies in New Zealand by revenue
Frequently Asked Questions Regarding GEn1E Lifesciences
Sign Up For FreeTo access detailed company insights
GEn1E Lifesciences is a multitarget platform for novel, next generation immunomodulators for rare and inflammatory diseases. By applying machine learning to its "platform in a mechanism" model, GEn1E has developed a pipeline of 21+ novel compounds. Their lead compound is a purpose-built therapy for acute respiratory distress syndrome (ARDS), a seri... Read More
